Skip to main content
. 2017 May 17;14(1):1089–1096. doi: 10.3892/ol.2017.6187

Table I.

Characteristics of three selected patients with metastatic RCC.

Patient Gender Age, years Diagnosis TNM stage Metastasis First-line TKI
A Male 60 RCC, clear cell T3b-N2-M1 Osseous, peritoneal, pulmonary, muscular Sunitinib
B Male 63 RCC, clear cell No primary tumor detectable Osseous, pulmonary, chest wall Sunitinib
C     Female 68 RCC, clear cell, sarcomatoid pT3a-pNx-cM1 Pulmonary, mediastinal lymph nodes Sunitinib

RCC, renal cell carcinoma; TNM, tumor-node-metastasis; TKI, tyrosine kinase inhibitor.